Plasmapheresis Market to be Worth $2.55 Billion by 2030
Meticulous
Research®—a
leading global market research company, published a research report
titled, ‘Plasmapheresis Market by
Product (Instruments, Disposables), Technology (Membrane Filtration,
Centrifugation), Application (Therapeutic [Immunology, Neurology, Hematology],
Plasma Collection), End User (Biopharma, Hospitals) - Global Forecast to
2030.’
Download
Free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=3092?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=15-01-2024
According
to this latest publication from Meticulous Research®,
the plasmapheresis market is projected to reach $2.55 billion by 2030, at a
CAGR of 8.6% from 2023 to 2030. The growth of this market is driven by the
rising incidence of autoimmune diseases, increasing demand for source plasma
from biopharmaceutical companies, and favorable reimbursement policies for
plasmapheresis procedures. In addition, the rising demand for plasmapheresis
from emerging countries is expected to provide significant growth opportunities
for this market.
However,
the high cost of plasmapheresis devices & procedures and the risks
associated with plasmapheresis procedures are expected to hinder the growth of
this market to a certain extent. In addition, factors such as lack of awareness
about plasmapheresis procedures and limited access and availability in certain
regions are the major challenges to market growth.
Plasmapheresis
Market: Future Outlook
The
plasmapheresis market is segmented by product, technology, application, end
user, and geography. The study also evaluates industry competitors and analyzes
the country and regional-level markets.
Based
on product, in 2023, the disposables
segment is expected to account for the largest share of the plasmapheresis
market. The large market share of this segment is attributed to the recurring
utilization of the plasma separation filters and administration sets for the
plasmapheresis procedures.
Based
on technology, in 2023, the
centrifugation segment is expected to account for the largest share of the
plasmapheresis market. The large market share of this segment is attributed to
the efficient separation of the plasma from other blood components in a short
time with the help of technology.
Based
on application, in 2023, the source plasma
collection segment is expected to account for the largest share of the
plasmapheresis market. The large market share of this segment is attributed to
the increased demand for source plasma from the pharmaceutical and biotechnology
companies, increased demand for plasma proteins and increased awareness about
voluntary plasma donations.
Speak to
analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3092?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=15-01-2024
Based
on end user, in 2023, the source plasma
collection segment is expected to account for the largest share of the
plasmapheresis market. The large market share of this segment is attributed to
the growing demand for source plasma for manufacturing plasma-derived products
using plasma fractionation methods.
Geographic
Review
This
research report analyzes the market across major regions and provides a
comprehensive analysis of North America (U.S. and Canada), Europe (Germany,
France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific
(Japan, China, India, Australia, and Rest of Asia-Pacific), Latin America, and
the Middle East & Africa.
In
2023, North America is expected to account for the largest share of the
plasmapheresis market, followed by Europe and Asia-Pacific. North America’s
major market share is attributed to high awareness about therapeutic
applications of plasmapheresis, high prevalence of autoimmune diseases, greater
adoption of advanced technologies, and well-established healthcare
infrastructure.
Key
Players
The
key players operating in the plasmapheresis market are Asahi Kasei Corporation
(Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun
Melsungen AG (Germany), SB-Kawasumi Laboratories, Inc (Japan), Kaneka
Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co.
KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed
SA (Switzerland).
Key
questions answered in the report:
· Which
are the high-growth market segments in terms of product, technology,
applications, end user, and region/country?
· What
was the historical market size for plasmapheresis across the globe?
· What
are the market forecasts and estimates for the period 2023–2030?
· What
are the major drivers, restraints, opportunities, and challenges in the global
plasmapheresis market?
· Who
are the major players in the plasmapheresis market?
· How
is the competitive landscape, and who are the market leaders in the global
plasmapheresis market?
· What
are the recent developments in the global plasmapheresis market?
· What
are the different strategies adopted by the major players in the global
plasmapheresis market?
· What
are the geographical trends and high-growth regions/countries?
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment